SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001616
Filing Date
2022-05-16
Accepted
2022-05-16 13:42:41
Documents
49
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220331x10q.htm   iXBRL 10-Q 848433
2 EX-31.1 tmb-20220331xex31d1.htm EX-31.1 14107
3 EX-31.2 tmb-20220331xex31d2.htm EX-31.2 14133
4 EX-32.1 tmb-20220331xex32d1.htm EX-32.1 7405
5 EX-32.2 tmb-20220331xex32d2.htm EX-32.2 7290
  Complete submission text file 0001410578-22-001616.txt   4311901

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220331.xsd EX-101.SCH 42404
7 EX-101.CAL tmb-20220331_cal.xml EX-101.CAL 22102
8 EX-101.DEF tmb-20220331_def.xml EX-101.DEF 192805
9 EX-101.LAB tmb-20220331_lab.xml EX-101.LAB 322738
10 EX-101.PRE tmb-20220331_pre.xml EX-101.PRE 269980
43 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220331x10q_htm.xml XML 614731
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40119 | Film No.: 22927515
SIC: 6770 Blank Checks
Office of Real Estate & Construction